Framingham Heart Study

From GM-RKB
Jump to navigation Jump to search

A Framingham Heart Study is a prospective cohort clinical study and a longitudinal study that is a cardiovascular (heart disease) clinical study based on subjects from Framingham, MA.



References

2023

  1. 1.0 1.1 Mahmood, Levy; Vasan, Wang (2013). "The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective" (fee required). Lancet. 383 (9921): 999–1008. doi:10.1016/S0140-6736(13)61752-3. PMC 4159698. PMID 24084292.
  2. Thomas R. Dawber, M.D., Gilcin F. Meadors, M.D., M.P.H., and Felix E. Moore Jr., National Heart Institute, National Institutes of Health, Public Health Service, Federal Security Agency, Washington, D. C., Epidemiological Approaches to Heart Disease: The Framingham Study Presented at a Joint Session of the Epidemiology, Health Officers, Medical Care, and Statistics Sections of the American Public Health Association, at the Seventy-eighth Annual Meeting in St. Louis, Mo., November 3, 1950.

1951

1950

  • (Thomas et al., 1950) ⇒ Thomas R. Dawber, M.D., Gilcin F. Meadors, M.D., M.P.H., and Felix E. Moore Jr.. (1950). “Federal Security Agency, Washington, D. C., Epidemiological Approaches to Heart Disease: The Framingham Study." Presented at a Joint Session of the Epidemiology, Health Officers, Medical Care, and Statistics Sections of the American Public Health Association, at the Seventy-eighth Annual Meeting in St. Louis, Mo., November 3, 1950.